[Clinical trial of Otipax: auricular pulverizations].
D000293:Adolescent; D000328:Adult; D000438:Alcohols; D000632:Aminopyrine / Q000627:therapeutic use*; D002648:Child; D004357:Drug Synergism; D005260:Female; D005990:Glycerol; D006801:Humans; D007223:Infant; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy*; D012964:Sodium; D013885:Thiosulfates / Q000627:therapeutic use*
D000438:Alcohols; D013885:Thiosulfates; D000632:Aminopyrine; D008012:Lidocaine; D012964:Sodium; D005990:Glycerol
Expérimentation clinique de l'Otipax: pulvérisations auriculaires.